Treatment of intravenous drug users with chronic hepatitis C: Treatment response, compliance and side effects

Hippokratia

Volumn 11, Issue 4, 2007, Pages 196-198

  Gigi, E ^a   Sinakos, E ^a   Lalla, Th ^a   Vrettou, E ^a   Orphanou, E ^a   Raptopoulou, M ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

HCV infection; IFN IFN ribavirin combination treatment; Intravenous drug users

Indexed keywords

ALPHA INTERFERON; METHADONE; PEGINTERFERON; RIBAVIRIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONOTHERAPY; PATIENT COMPLIANCE; SEX RATIO; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 35349019195     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wood E, Kerr T, Stoltz J, et al. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. Public Health 2005; 119: 1111-1115
2. Raptopoulou M, Lalla E, Vakolas J, et al. Prevalence of HCV infection and liver damage in ex-drug addicts. J Hepatol 1997; 26 (Suppl 1): 203
3. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002; 36(Suppl 1): S1-S52
4. Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alpha and ribavirin in psychiatric risk groups. Hepatology 2003; 37:443-451
5. Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 2004; 99:1167-1175
6. Mauss S, Berger F, Goelz J, Jacob B, Schmutz G. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology 2004; 40:120-124
7. Sylvestre DL. Approaching treatment for hepatitis C virus in substance users. Clin Infect Dis 2005; 41 (Suppl 1): S79-S82
8. Grebely J, Duncan F, Viljoen M, et al. Directly Observed Therapy (DOT) for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUS) - An interim analysis. Hepatology 2005; 42 (Suppl 1): 686A
9. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982
10. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358:958-965